Maddie Major has benefitted from breakthrough cancer research originally funded by ACGT. She has battled leukemia for 4 years – but now her test are negative thanks to cancer gene therapy.
Medical science has been trying for 40 years to harness the immune system to cure cancer, or at least turn it into a docile chronic disease. Excitement has invariably been followed by disappointment.
But after 30 months of testing in more than a dozen adults and children – patients with no conventional options left – worldwide excitement over the T cell therapy’s unprecedented power continues to build.
Read more about Maddie’s extraordinary story – Pinning their Hopes on a Penn Gene Therapy by Marie McCullough, Philadelphia Inquirer